You're reading the free version. Trader adds the live tape and alerts.
Start tracking
UTHR Sale Disclosure
Rothblatt Martine A · SEC Form 4 · Filed Sep 28, 2026
Sale
Calculated transaction value
$766.62K
Rothblatt Martine A Chairperson & CEO
UTHR
Transaction date
Sep 25, 2026
Public filing date
Sep 28, 2026
Filing lag
Filed 3 days later
UTHR daily price context
Close on/before transaction
$475.45
Sep 25, 2026
First close after public filing
$481.47
Sep 29, 2026
30-day return after filing
+21.81%
Through Oct 28, 2026
Source details
- Reported owner
- Not disclosed
- Source asset code
- Security
- Security
- Common Stock
- Quantity / price
- 1,613 shares @ $475.28
- SEC ownership
- Indirect
- Transaction code
- S
- Form
- 4
- Filing identifier
- 0001106578-26-000150
Filing cohort
Transactions in this filing
Showing 11 of 11
Trades
11
Issuers
1
Estimated value
$5.64M
Buys / sales
0 / 9
| Issuer | Transaction | Traded | Value |
|---|---|---|---|
| United Therapeutics Corp UTHR | Exercise | Sep 25, 2026 | $1.12M |
| United Therapeutics Corp UTHR | Sale | Sep 25, 2026 | $18.82K |
| United Therapeutics Corp UTHR | Sale | Sep 25, 2026 | $94.37K |
| United Therapeutics Corp UTHR | Sale | Sep 25, 2026 | $378.31K |
| United Therapeutics Corp UTHR | Sale | Sep 25, 2026 | $257.46K |
| United Therapeutics Corp UTHR Current | Sale | Sep 25, 2026 | $766.62K |
| United Therapeutics Corp UTHR | Sale | Sep 25, 2026 | $1.31M |
| United Therapeutics Corp UTHR | Sale | Sep 25, 2026 | $610.81K |
| United Therapeutics Corp UTHR | Sale | Sep 25, 2026 | $788.04K |
| United Therapeutics Corp UTHR | Sale | Sep 25, 2026 | $302.7K |
| United Therapeutics Corp UTHR | Exercise | Sep 25, 2026 | $0 |